Dimensional US Small Cap ETF's Holdings Offer Potential 15% Gain
ByAinvest
Thursday, Oct 2, 2025 9:40 am ET1min read
AVTX--
Among the ETF's holdings, Precision Biosciences (DTIL) and Avalo Therapeutics (AVTX) stand out with substantial upside potential. DTIL is projected to gain 440.44%, while AVTX is expected to increase by 159.77% [2]. Additionally, Cineverse (CNVS) is also seen as a promising investment with a 149.27% upside [2].
These projections come as the U.S. crypto market braces for a busy October, with the SEC set to rule on a wave of altcoin ETF applications, including one for Solana [1]. The potential regulatory approval of crypto ETFs could provide a boost to the overall market sentiment and, consequently, the performance of related investments.
The outlook for these stocks and the ETF is based on a combination of factors, including analyst research, market conditions, and the potential impact of regulatory decisions. While the projections are encouraging, it is essential for investors to conduct their own due diligence and consider their risk tolerance and investment objectives before making any investment decisions.
CNVS--
DTIL--
SOL--
The Dimensional US Small Cap ETF (DFAS) has a potential 15% gain based on analyst targets for its underlying holdings. Precision Biosciences (DTIL), Avalo Therapeutics (AVTX), and Cineverse (CNVS) have notable upside to their analyst targets. Analysts see a 14.91% upside for DFAS, with 440.44% upside for DTIL, 159.77% upside for AVTX, and 149.27% upside for CNVS.
Analysts are projecting significant gains for the Dimensional US Small Cap ETF (DFAS) and several of its underlying holdings. The DFAS, which focuses on small-cap U.S. stocks, is expected to see a 14.91% increase based on analyst targets [1].Among the ETF's holdings, Precision Biosciences (DTIL) and Avalo Therapeutics (AVTX) stand out with substantial upside potential. DTIL is projected to gain 440.44%, while AVTX is expected to increase by 159.77% [2]. Additionally, Cineverse (CNVS) is also seen as a promising investment with a 149.27% upside [2].
These projections come as the U.S. crypto market braces for a busy October, with the SEC set to rule on a wave of altcoin ETF applications, including one for Solana [1]. The potential regulatory approval of crypto ETFs could provide a boost to the overall market sentiment and, consequently, the performance of related investments.
The outlook for these stocks and the ETF is based on a combination of factors, including analyst research, market conditions, and the potential impact of regulatory decisions. While the projections are encouraging, it is essential for investors to conduct their own due diligence and consider their risk tolerance and investment objectives before making any investment decisions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet